Revenue
$94.2B
▲ 6.0% YoY
Net Income
$26.8B
▲ 90.6% YoY
EPS
$11.03
▲ 90.5% YoY
Cash
$19.7B
▼ 18.2% YoY
FY 2025 · As of 2025-12-28
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Taubert Jennifer L EVP, WWC. Innovative Medicine | Vest | Aug 17, 2026 | 15.0K | $115.67 | $1.74M | Form 4 ↗ |
Taubert Jennifer L EVP, WWC. Innovative Medicine | Sell | Aug 17, 2026 | 15.0K | $263.36 | $3.95M | Form 4 ↗ |
Duato Joaquin CEO and Chairman of the Board | Vest | Aug 13, 2026 | 123.3K | $115.67 | $14.26M | Form 4 ↗ |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 13, 2026 | 21.0K | $262.00 | $5.50M | Form 4 ↗ |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 13, 2026 | 102.3K | $261.00 | $26.70M | Form 4 ↗ |
Forminard Elizabeth EVP, Chief Legal Officer | Vest | Aug 6, 2026 | 9.3K | $131.94 | $1.23M | Form 4 ↗ |
Forminard Elizabeth EVP, Chief Legal Officer | Sell | Aug 6, 2026 | 9.3K | $257.75 | $2.41M | Form 4 ↗ |
Forminard Elizabeth EVP, Chief Legal Officer | Sell | Aug 6, 2026 | 6.6K | $255.93 | $1.68M | Form 4 ↗ |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 5, 2026 | 42.0K | $258.06 | $10.83M | Form 4 ↗ |
Duato Joaquin CEO and Chairman of the Board | Sell | Aug 5, 2026 | 6.5K | $258.74 | $1.69M | Form 4 ↗ |
Broadhurst Vanessa EVP, Global Corp Affairs | Vest | Jul 20, 2026 | 11.1K | $129.51 | $1.44M | Form 4 ↗ |
Broadhurst Vanessa EVP, Global Corp Affairs | Vest | Jul 20, 2026 | 11.9K | $131.94 | $1.57M | Form 4 ↗ |
Broadhurst Vanessa EVP, Global Corp Affairs | Sell | Jul 20, 2026 | 23.1K | $251.27 | $5.79M | Form 4 ↗ |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Vest | Jun 11, 2026 | 10.0K | $115.67 | $1.16M | Form 4 ↗ |
Wengel Kathryn E EVP, Chief TO and Risk Officer | Sell | Jun 11, 2026 | 10.0K | $241.15 | $2.41M | Form 4 ↗ |